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NucleoplasmMicrospherule protein Msp58 (or MCRS1) plays a role in numerous cellular processes including transcriptional
regulation and cell proliferation. It is not well understood either how Msp58 mediates its myriad functions or
how it is itself regulated. Here, by immunoprecipitation, we identify EDD (E3 identiﬁed by differential display)
as a novel Msp58-interacting protein. EDD, also called UBR5, is a HECT-domain (homologous to E6-AP carboxy-
terminus) containing ubiquitin ligase that plays a role in cell proliferation, differentiation and DNA damage
response. Both in vitro and in vivo binding assays show thatMsp58 directly interacts with EDD.Microscopy studies
reveal that these two proteins co-localize in the nucleus. We have also found that depletion of EDD leads to an in-
crease of Msp58 protein level and extends the half-life of Msp58, demonstrating that EDD negatively regulates
Msp58's protein stability. Furthermore, we show that Msp58 is upregulated in multiple different cell lines upon
the treatment with proteasome inhibitor MG132 and exogenously expressed Msp58 is ubiquitinated, suggesting
that Msp58 is degraded by the ubiquitin–proteasome pathway. Finally, knockdown of either Msp58 or EDD in
human lung ﬁbroblastWI-38 cells affects the levels of cyclins B, D and E, as well as cell cycle progression. Together,
these results suggest a role for the Msp58/EDD interaction in controlling cell cycle progression. Given that both
Msp58 and EDD are often aberrantly expressed in various human cancers, our ﬁndings open a new direction to
elucidate Msp58 and EDD's roles in cell proliferation and tumorigenesis.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Microspherule protein 58 kDa (Msp58, also known as MCRS1) was
originally identiﬁed as a nucleolar protein, and, consistent with that
localization, it has since been found to regulate transcription of rRNA
genes [1,2]. Msp58 is also found within the nucleoplasm, however,
and is now recognized to play a role in many other cellular processes
[2–6]. For example, several studies have shown that Msp58 binds to in-
dividual transcription factors, modulating their effects on target genes
[2,4,5]. Msp58/MCSR1 also binds to the minus ends of kinetochore mi-
crotubules, preventing depolymerization by microtubule depolymerase
and thereby modulating the stability of mitotic spindles [7]. Msp58
may have additional roles in cell cycle regulation through its transcrip-
tional effects on the cyclin genes [8]. Interestingly, a recent study indi-
cates that ectopic expression of Msp58 affects the protein levels ofa; EDD, E3 identiﬁed by differ-
rboxy-terminus-domain; FHA,
ignal; siRNA, small interfering
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rights reserved.important regulators of cell cycle, including cyclins, and has distinctive
effects in cell proliferation in a cell context-dependent manner [9].
The Msp58 gene is evolutionarily conserved from ﬂies to humans
[1,3,10]. Current understanding of the functions of Msp58, however,
have come mostly from studies focused on other proteins, where
these proteins were used as “bait” and then Msp58 identiﬁed as a
binding partner in yeast two-hybrid screens. In this study, we focused
on Msp58, looking for binding partners that might reveal more about
the natural cellular functions of this highly conserved protein. Upon
immunoprecipitating Msp58 from HeLa S3 nuclear extracts, we found
several potential interacting proteins, but by far the most abundant
was the E3 ubiquitin ligase EDD (E3 identiﬁed by differential display).
EDD (also called hHYD or UBR5) is an ortholog of Drosophila
melanogasterHyd, an E3 ubiquitin-protein ligase encoded by tumor sup-
pressor gene hyperplastic discs (hyd) [11,12]. EDD is a nuclear protein
that belongs to the family of HECT domain-containing (homologous to
E6-AP carboxy-terminus) ubiquitin ligases. Like Msp58, EDD plays a
role in cell cycle regulation [13–15]. EDD also has important functions
in the DNA damage response [13–18].
In the current study, we show, by immunoﬂuorescence and confocal
microscopy, that Msp58 and EDD co-localize in the nucleoplasm. Our
domain analyses reveal a direct association of Msp58 with EDD via a
region upstream of EDD's E3 ligase domain and demonstrate that two
independent regions of Msp58 are sufﬁcient to bind EDD. Depletion of
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suggesting that EDD is a negative regulator of Msp58 (EDD's ubiquitin
ligase activity may or may not be involved). Interestingly, additional
experiments suggest that the Msp58/EDD interaction serves to control
aspects of cell cycle progression. Upon silencing Msp58 alone, there
was a pronounced depletion of Msp58 protein and this was accompa-
nied by an increase in both cyclin D3 and cyclin B levels, leading to a
stall at G2/M. Depletion of EDD alone or in combination with Msp58
provided further evidence for the importance of these two proteins
and their relative expression levels to normal cell cycle progression.
2. Materials and methods
2.1. Cell Culture
HeLa and HEK293T cells were grown at 37 °C with 5% CO2 in
Dulbecco's modiﬁed Eagle's medium supplemented with 10% fetal
bovine serum, 100 units/ml penicillin, and 100 mg/ml streptomycin.
WI-38 cells were maintained in ATCC Minimum Essential Medium
Eagle supplemented as described above.
2.2. Cycloheximide (CHX) and MG132 treatment
WI-38, HeLa and HEK293T cells were treated with 20 μg/ml
cycloheximide (Sigma; diluted in ethanol) in the presence or
absence of 40 μM MG132 (BostonBiochem; diluted in DMSO) for
6 h before harvest. Diluent (ethanol/DMSO) was used as control.
2.3. Antibodies
Rabbit anti-Msp58 serum was raised against GST-Msp58
(Reamstown, PA) and the antibodies were puriﬁed using recombi-
nant FLAG-Msp58. Rabbit anti-EDD serum was raised against re-
combinant EDD (amino acids 2475–2799) fragment (Reamstown,
PA) and the antibodies were puriﬁed using GST-EDD (amino acids
2475–2799). Mouse anti-EDD serum was raised against recombi-
nant GST-EDD (amino acids 2475–2799). Commercial antibodies
used in this study were as follows: FLAG (Sigma); EDD (M-19),
His6 tag, GFP and GAPDH (Santa Cruz); S tag (Novagen); cyclins B
and E (BD Biosciences); cyclins D1 and D3 (Cell Signaling); and
mAb414 (Covance).
2.4. Small interfering RNAs (siRNAs) and transfection
siRNAs targeting EDD (GenBank accession number NM_015902)
were designed using the Whitehead siRNA design program (http://
jura.wi.mit.edu/siRNAext/). The sequences of the effective EDD siRNAs
used in this study are as follows: sense strand 5′-GGCAAAUCCAG
AAGUGUCAdTdT, antisense strand 5′-UGACACUUCUGGAUUUGCCdTdT.
The siRNAs were synthesized and processed by Dr. Thomas Tuschl
laboratory at the Rockefeller University. The siRNAs against Msp58
(GenBank accession number AF015308) were designed using the
Integrated DNA Technologies (IDT) SciTools RNAi Design program and
were synthesized by IDT. The sequences are as follows: sense strand
5′-GUGGCAGGUGCUAGUGGACAGCATC and antisense strand 5′-GAUG
CUGUCCA CUAGCACCUGCCACUU. GFP siRNAs (Dharmacon) were used
as control siRNA. For WI-38, ~1×105 cells/well were seeded in 6 well
plates the day before transfection. The cells were transfected with
100 nM siRNAs using Lipofectamine RNAiMAX (Invitrogen) and the
medium was changed 5 h later. After a 48-h incubation, cells were
trypsinized and transferred to 6 cm plates. For HeLa, ~4×105 cells/well
were seeded in 6 well plates and transfected as described above. About
6 hpost-transfection, cellswere trypsinized and re-seeded in 6 cmplates.
For HEK293T, ~1.5×106 cells/well were seeded in 6 cmplates. Cellswere
transfected with 100 nM siRNAs using calcium phosphate method aspreviously described [19]. Seventy-two hours after transfection, WI-38,
HeLa and HEK293T cells were harvested and analyzed accordingly.
2.5. Plasmids
Full-length human Msp58 coding sequence was ampliﬁed from
HeLa cDNA (Clontech) and cloned into pIRESneo (Clontech) for ex-
pressing FLAG-Msp58. The Msp58 coding sequence was cloned into
pEGFP-C1 (BD Biosciences), pGEX-4T-3 (GE Healthcare), and pET28hx
(a gift from Dr. T. Schwartz) to express GFP-Msp58, GST-Msp58 and
His6-Msp58-FLAG, respectively. Different cDNAs coding for human
EDD fragments (EDDFR12, EDDFR35, EDDFR45, EDDFR1, EDDFR4 or
EDDFR5) were obtained by PCR from human testis cDNA library
(Clontech) and then cloned into the Not I/Apa I sites of pcDNA3.1+-HisB
(Invitrogen). The cDNAs for EDDFR4 and EDDFR5 were also cloned into
the Nde I/Xho I sites of pETDuet-1 (Novagen) to express C-terminal S
tagged EDDFR4-S and EDDFR5-S. The cDNAs for Msp58 and its deriva-
tives were ampliﬁed by PCR from FLAG-Msp58 expression vector and
cloned into the EcoR I/Hind III sites of aforementioned EDDFR4-S or
EDDFR5-S expression constructs to co-express N-terminal His6-tagged
Msp58 and its derivatives. All the constructs were veriﬁed by DNA
sequencing. HA-Ub and FLAG-EDD expression constructs were gener-
ously provided by Drs. P. Zhou and D. Saunders, respectively.
2.6. Cell line establishment and afﬁnity puriﬁcation of protein complexes
HeLa S3 cells grown in DMEM with 10% FBS were transfected with
the FLAG-Msp58 expression construct using Effectene Transfection
reagent (QIAGEN) according to the manufacturer's instruction. G418
(500 μg/ml) was added to the medium for selection [20]. Positive
clones were conﬁrmed by immunoblotting the lysate using anti-FLAG
antibody (Sigma). Preparation of nuclear extracts and afﬁnity puriﬁca-
tion were carried out by following the protocol previously described
[20]. Brieﬂy, nuclear extracts prepared from FLAG-Msp58 stably
transfected HeLa S3 cells were adjusted to contain 0.2% NP-40 and
incubated with anti-FLAG M2-agarose beads (Sigma) at 4 °C for 6 h.
After extensive washing with BC300 buffer (20 mM HEPES, pH 7.9,
300 mM KCl, 0.2 mM EDTA, 0.5 mM DTT, 20% glycerol) containing
0.2% NP-40, the associated complexes were eluted from beads by incu-
bating at 4 °C for 60 min with BC100/0.2% NP-40 containing 0.5 mg/ml
FLAG peptide (Sigma).
2.7. Mass spectrometric protein identiﬁcation
The afﬁnity-puriﬁed proteins were resolved by SDS-PAGE. The pro-
tein bands that were speciﬁc to the eluate of the FLAG-Msp58 sample,
compared with the HeLa S3 control, were excised from a Coomassie
blue stained gel, digested with trypsin, followed by protein identiﬁcation
by liquid chromatography–tandemmass spectrometry (LC-MS/MS) car-
ried out in ProtTech (Norristown, PA).
2.8. Protein expression and binding assays
Recombinant S-tagged EDD fragments and His6-taggedMsp58were
co-expressed from pETDuet-1 vector (Novagen) in bacteria BL21 (DE3)
CodonPlus (RPIL) (Agilent) and puriﬁed either using cobalt beads (GE
Healthcare) or S-tag agarose (Novagen). GST-Msp58 was expressed
in bacteria BL21 (DE3) and puriﬁed using Glutathione Sepharose 4B
(GE Healthcare). The puriﬁcations were performed according to the
manufacturer's manuals. The EDD fragments used in Fig. 2B were pro-
duced using the TNT T7 quick coupled transcription/translation system
(Promega) in the presence of 35S-Met (ICN, Irvine, CA). For each reac-
tion of binding assay in Fig. 2B, 20 μl of beads immobilized with recom-
binant GST-Msp58 (or GST) were incubated with in vitro translated
protein in 36 μl of TBT buffer (20 mM Hepes, pH 7.4, 110 mM KOAc,
2 mMMgCl2, 0.1% Tween 20) containing complete EDTA free protease
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teins were eluted with SDS-sample buffer and resolved by SDS-PAGE,
followed by autoradiography.
2.9. Immunoblotting
Immunoblotting was carried out as previously described [21], except
that cell lysates were prepared using ProteoJET Mammalian Cell Lysis
Reagent (Fermentas) or M-PER Mammalian Protein Extraction Reagent
(Thermo Scientiﬁc), containing protease inhibitors (Calbiochem), fol-
lowing themanufacturer's protocol. GAPDHwas used as loading control.
2.10. Immunoﬂuorescence and confocal microscopy
GFP-Msp58 expression plasmid was transfected into HeLa cells
using Lipofectamine-2000 reagent (Invitrogen). HeLa and WI-38 cells
grown on coverslips were ﬁxed, permeabilized and immunolabeled
following protocols previously described [21]. FITC-conjugated goat
anti-mouse and Cy5-conjugated donkey anti-rabbit IgG antibodies
(Jackson ImmunoResearch) were used. Samples were analyzed using
a Leica TCS SP2 confocal microscope in the Bio-Imaging Facility at
Hunter College.
2.11. Immunoprecipitation
HEK293T cells were seeded in 10 cm plates (~6×106 cells/plate).
Next day, cells were co-transfected with FLAG-EDD in combination
with either GFP-Msp58 or GFP expression constructs, using calcium
phosphate method as previously described [19]. Forty-eight hours
post-transfection, cells were washed once and harvested with PBS
(137 mM NaCl, 2.7 mM KCl, 5.4 mM Na2HPO4, and 1.8 mM KH2PO4).
The cell pellet was resuspended in 1 ml PBS and split for input
(100 μl) and immunoprecipitation (IP; 900 μl). For input samples,
cells were pelleted and lysed with 80 μl of M-PER Mammalian Protein
Extraction Reagent (Thermo Scientiﬁc), containing protease inhibi-
tors, following the manufacturer's protocol. IP was carried out follow-
ing Sigma's Anti-FLAG M2 Afﬁnity Gel protocol. For IP samples, cells
were pelleted and resuspended in 1 ml of 1% Triton X-100 lysis buffer
(50 mM Tris–HCl pH 7.5, 150 mMNaCl, 1 mM EDTA, 1% Triton X-100,
and protease inhibitors). Cell suspensions were then shaken at
1.2K rpm at 4 °C for 10 min and sonicated three times (5 s each),
followed by centrifugation atmaximum speed for 25 min at 4 °C. Cell ly-
sates were incubated with 20 μl beads of anti-FLAG M2 afﬁnity gel for
1 h at 4 °C with rotation. The beads were then washed four times with
1 ml TBS (50 mM Tris–HCl, 150 mMNaCl, pH 7.4). Immunoprecipitates
were eluted in 40 μl of 3XFLAG peptide solution (150 ng/μl) and then
analyzed by immunoblotting with speciﬁed antibodies.
For in vivo ubiquitination assay, HEK293T cells were seeded at
~4×106 cells per 10 cm plate the day before transfection. Cells were
co-transfected with HA-Ub and GFP-Msp58 (or GFP) expression con-
structs and EDD or control siRNAs (Reverse Lamin siRNA, Dharmacon)
using calcium phosphate method. Seventy-two hours after transfection,
fresh medium containing MG132 was added and cells were incubated
for additional 6 h before harvesting. Cells were harvested and the
input samples were prepared as aforementioned. Immunoprecipitation
was carried out as previously described with some modiﬁcations [19].
Speciﬁcally, cells were pelleted, resuspended in 300 ul of 1% SDS lysis
buffer (50 mM Tris–HCl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, 1% SDS,
and protease inhibitors), sonicated two times (10 s each), and boiled
at 80 °C for 30 min, followed by centrifugation at the maximum speed
for 25 min at 4 °C. Lysates were diluted (1:10) in NP40 lysis buffer
(50 mM Tris–HCl pH 8.0, 150 mM NaCl, 5 mM EDTA pH 8.0, 1% NP40,
and protease inhibitors) and incubated with 25 μl of anti-HA afﬁnity
matrix (Sigma) for 1 h at 4 °C with rotation. The beads were then
washed four times with 1 ml of binding buffer. Immunoprecipitateswere eluted in 50 μl of 2× SDS-PAGE sample buffer. The inputs and
eluates were analyzed by immunoblotting as described.
2.12. Msp58 protein half-life analysis
Seventy-two hours after transfectionwith EDD or GFP siRNAs (as de-
scribed in Section 2.3), HeLa cells were either left untreated or treated
with cycloheximide for the indicated time before harvesting. The sam-
ples were analyzed by immunoblotting with speciﬁed antibodies.
Immunoblots were quantiﬁed using ImageJ software. Msp58 protein
was compared with loading control (GAPDH). The Msp58/GAPDH
ratio at t=0 was arbitrarily set to 1, and the ratios of remaining time
points were normalized to the value of t=0.
2.13. Flow cytometry
Seventy-two hours after transfection with siRNAs, subconﬂuent
WI-38 cells were harvested by trypsinization and ﬁxed overnight in
cold 70% ethanol at 4 °C. The cells were then washed and resuspended
in a PBS solution containing 50 μg/ml propidium iodide (PI), 200 μg/ml
RNase A, 2 mM EDTA and 0.1% Triton X-100, incubating at 37 °C for
30 min. Labeled cells were analyzed using Becton Dickinson FACScalibur
system in the Flow-Cytometry Facility at Hunter College. Cell cycle pop-
ulation distributionwas analyzedwith DNA analysis softwareMultiCycle
AV (Phoenix Flow Systems).
3. Results
3.1. EDD is a novel interacting protein of Msp58
To elucidate the molecular mechanisms by which Msp58 carries
out its functions, we used immunoprecipitation (IP) to isolate the
proteins that associate with Msp58 in vivo. We ﬁrst generated a
HeLa S3 cell line, designated HeLa/FLAG-Msp58, that stably expresses
FLAG-tagged Msp58. Using anti-FLAG M2 agarose, FLAG-Msp58 and
its interacting proteins were immunoprecipitated from the nuclear
extract of HeLa/FLAG-Msp58 cells. The nuclear extract of the parental
HeLa S3 cells was used as a control. The eluates of the IP were
resolved by SDS-PAGE and visualized by silver staining. As shown in
Fig. 1A, the eluate from HeLa/FLAG-Msp58 cells (lane 2) yielded a
prominent protein band larger than 250 kDa. The band containing
this protein was identiﬁed by tandem liquid chromatography mass
spectrometry (LC-MS/MS) to be EDD (E3 identiﬁed by differential
display). In total, 19 peptides matching EDD were identiﬁed, covering
10.5% of 2799 amino acids of EDD (Fig. 1A). EDD is a member of the
HECT ubiquitin-protein ligase family and plays a critical role in cell
proliferation and differentiation, as well as in the DNA damage
response [11,17,18,22,23]. By immunoblotting the eluates with an
EDD antibody (Santa Cruz), we conﬁrmed that EDD was speciﬁcally
copuriﬁed with FLAG-Msp58 (Fig. 1B). In addition, we carried out a
reverse IP to test whether Msp58 could be pulled down by EDD.
This IP was performed using lysates of HEK293T cells co-transfected
with FLAG-EDD and GFP-Msp58 (or control GFP) expression con-
structs. The eluates were analyzed by immunoblotting using anti-
bodies against both Msp58 (lanes 3 and 4) and GFP (lanes 7 and 8)
(Fig. 1C). The results clearly indicate that GFP-Msp58, but not GFP,
co-puriﬁed with FLAG-EDD. Thus, we have identiﬁed EDD as a novel
Msp58-associated protein.
3.2. Msp58 interacts with EDD in vitro via a region upstream of the HECT
domain
To determine which region(s) of EDD mediates its interaction
with Msp58, we carried out domain analyses. As shown in Fig. 2A,
EDD contains a ubiquitin-associated (UBA) domain, three nuclear lo-
calization signals (NLSs), a cysteine/histidine-rich putative zinc ﬁnger
Fig. 1. Identiﬁcation of a novel nuclear protein complex containing Msp58 and EDD. (A) Nuclear extract from HeLa S3 cells or HeLa S3 cells stably expressing FLAG-Msp58 was
immunoprecipitated with anti-FLAG M2 agarose. The eluates were examined by silver staining. EDD was identiﬁed by mass-spectrometry (LC-MS/MS). (B) The eluates were
immunoblotted with anti-FLAG and anti-EDD antibodies. Lanes 1 and 4: 5% of input, lanes 2 and 5: eluate from IP of the nuclear extract of the FLAG-Msp58 HeLa S3 stable line,
and lanes 3 and 6: eluate from IP of the nuclear extract of HeLa S3 cells (control). (C) Msp58 was co-puriﬁed with FLAG-EDD. Total lysates from HEK293T cells transiently expressing
FLAG-EDD and GFP-Msp58 were immunoprecipitated with anti-FLAGM2 agarose. Cells co-transfected with FLAG-EDD and GFP were used as control. Inputs (lanes 1, 2, 5 and 6) and
3X-FLAG peptide eluates (lanes 3, 4, 7, 8) were analyzed by immunoblotting with speciﬁed antibodies.
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like domain (PABP-C) and a HECT domain (ubiquitin ligase domain)
[17]. Fragments carrying different subsets of these domains were tested
for their binding to Msp58. These included EDDFR12 (amino acids
1–1141), EDDFR35 (amino acids 1142–2799), EDDFR45 (amino acids
1976–2799) and EDDFR4 (amino acids 1976–2474) (Fig. 2A). Each of
these fragments was cloned into the pcDNA3.1+-HisB plasmid, which
was further used to synthesize 35S-radiolabeled EDD fragments using
the rabbit reticulocyte lysate in vitro coupled transcription/translation
system. The resulting 35S-labeled proteinswere assayed for their binding
to a recombinant GST-Msp58 protein. Our results showed that EDDFR35,
EDDFR45 and EDDFR4, which all contain the EDDFR4 region, were ableto bindGST-Msp58, but not GST control (Fig. 2B). Therefore,we conclude
that the region included in EDDFR4, located upstream of the HECT
domain that contains the ubiquitin E3 ligase activity, is sufﬁcient to inter-
act with Msp58.
3.3. Msp58 directly interacts with EDD
The in vitro binding study shown in Fig. 2B used the EDD frag-
ments synthesized with the rabbit reticulocyte lysate system. Given
that other proteins present in the lysate may mediate the interaction
between Msp58 and EDD, we sought to determine whether Msp58
directly interacts with EDD. To this end, we further characterized
Fig. 2.Msp58 interacts with EDD via the EDDFR4 (1976–2474) region. (A) Schematic diagram of EDD and its derivative fragments that were used for in vitro binding assays. (B) The EDD
fragments that contain the FR4 (1976–2474) region speciﬁcally interactwithMsp58. RecombinantGST orGST-Msp58proteins immobilizedon theglutathionebeadswere incubatedwith
35S-Met labeled EDD fragments (FR12, FR35, FR45 and FR4). The eluates were resolved by SDS-PAGE, followed by autoradiography. 15% of input was loaded to show the expression levels
of proteins. (C) Coomassie blue staining of the lysates of uninduced (U, lanes 1 and 3) and induced (I, lanes 2 and 4) bacteria, co-expressing His6-Msp58 with EDD-FR5-S or EDD-FR4-S.
Asterisk points to a degradation product of EDD-FR4-S. (D) Immunoblotting of samples, as described in (C), with anti-His6 tag or anti-S tag antibodies. (E) Msp58 directly binds EDD-FR4,
but not EDD-FR5. Lysates of induced bacteria, as described in (C),were puriﬁedwith cobalt beads. The input (IN, lanes 1 and 3) and the eluates (E, lanes 2 and 4)were immunoblottedwith
anti-S tag antibody.
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system was used to simultaneously express recombinant Msp58 and
EDDFR4. EDDFR5 was used as a negative control. In this experiment,
the cDNAs coding for Msp58 and EDD fragments were cloned into
pETDuet-1 to express Msp58 and EDD fused with an amino-terminalHis6 tag and a carboxy-terminal S tag, respectively. The sequence-
conﬁrmed construct was transformed into E. coli BL21(DE3)Codon Plus
(RIL) cells for optimal protein expression. The lysates of uninduced
(lanes 1 and 3) and induced cells (lanes 2 and 4) were resolved
by SDS-PAGE, followed by Coomassie blue staining (Fig. 2C) or
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The results showed that His6-Msp58 and EDDFR4-S (or EDDFR5-S)
were properly expressed as expected. The induced bacterial lysates
were incubated with cobalt beads to purify His6-tagged proteins. After
extensive wash, the bound proteins were eluted with imidazole. As
shown in Fig. 2E, EDDFR4-S (lane 4), but not EDDFR5-S (lane 2), was
co-puriﬁed with His6-Msp58. Thus, our bacteria-based binding assay
proved that Msp58 directly interacted with EDD.3.4. Two separate regions of Msp58 are sufﬁcient to bind EDD
To characterize the interaction between Msp58 and EDD, we also
mapped the domain of Msp58 that binds EDD (Fig. 3A). The cDNAs
that encode different fragments of Msp58, amino acids 1–296 and
297–462, were cloned into a derivative of pETDuet-1 vector to co-
express His6-tagged Msp58 fragments with EDDFR4-S. Upon the con-
ﬁrmation of their expression by immunoblotting (lanes 4 and 6,
Fig. 3B), the bacterial lysates were incubated with S-protein agarose
to pull down EDDFR4-S. Our results showed that full length Msp58
and Msp58297–462 (lanes 2 and 6, Fig. 3C), but not Msp581-296 (lane 4,
Fig. 3C), were co-puriﬁed with EDDFR4-S. These results demonstrated
that the C-terminal region of Msp58 (amino acids 297–462) was sufﬁ-
cient to bind EDD.
Msp58297–462 contains a coiled-coil motif (amino acids 301–350)
and a forkhead-associated domain (FHA, amino acids 362–432)
(Fig. 3A), both known to mediate protein–protein interactions. Since
EDD has been shown to interact with the FHA domain of checkpoint
kinase CHK2 [16], we tested the possibility that EDD also binds
Msp58 via its FHA domain. We generated two additional constructs
that co-express EDDFR4 with Msp581–342 or Msp58343–462, the latter
mainly consisting of the FHA domain (amino acids 362–432) [1].
Immunoblotting analyses conﬁrmed that the recombinant proteins
were appropriately expressed (lanes 2 and 4, Fig. 3D). Using the
aforementioned approach, we showed that both Msp581–342 and
Msp58343–462 were able to bind EDDFR4 (lanes 4 and 6, Fig. 3E).
Msp581-296 was used as a negative control (lane 2, Fig. 3E). These
data indicate that the FHA domain and the region containing a
coiled-coil motif were each sufﬁcient to interact with EDD.3.5. Msp58 co-localizes with EDD in the nucleoplasm
We showed that Msp58 and EDD were present in a protein com-
plex puriﬁed from nuclear extracts (Fig. 1). In addition, results from
studies using reticulocyte lysate-translated and bacterially expressed
recombinant proteins demonstrated that Msp58 directly interacts
with EDD. We thus wanted to know whether Msp58 co-localizes
with EDD in vivo. We ﬁrst analyzed their individual localizations by
indirect immunoﬂuorescence and confocal microscopy. HeLa cells
were co-immunostained with mouse monoclonal mAb414 antibody,
which recognizes several nuclear pore proteins at the nuclear enve-
lope, and rabbit polyclonal antibodies against Msp58 (Fig. 4A, top)
or EDD (Fig. 4A, bottom). Both Msp58 and EDD were predominantly
detected in the nucleoplasm. Then, we addressed whether Msp58
and EDD colocalize in different mammalian cell types using two
approaches. First, we examined the localizations of endogenous pro-
teins in WI-38 (Fig. 4B, top) and HeLa (Fig. 4B, bottom) cells with
rabbit and mouse polyclonal antibodies against Msp58 and EDD,
respectively. Second, we transiently transfected HeLa cells with
GFP-Msp58, followed by immunostaining with rabbit polyclonal anti-
bodies against EDD. The results from both cell types consistently
showed that (i) Msp58 was mainly located in the nucleus with limit-
ed amounts in the cytoplasm, (ii) EDDwas predominantly localized in
the nucleoplasm and nucleoli, and (iii) Msp58 co-localized with EDD
in the nucleoplasm (Fig. 4).3.6. EDD regulates the protein level and stability of Msp58
EDD is an E3 ubiquitin ligase and several substrates of EDD have
been reported [18,24–27]. Since we showed that Msp58 directly
interacted with EDD, we asked whether the protein level of Msp58 is
also controlled by EDD. siRNAs targeting EDD were transfected into
WI-38, HeLa and HEK293T cells, and GFP siRNAs were used as control.
Seventy-two hours after transfection, the cells were harvested for im-
munoblotting analyses of Msp58 and EDD. Compared with control,
depletion of EDD led to a signiﬁcant accumulation of Msp58 in all ana-
lyzed cell lines (Fig. 5A). As these results indicated that EDD negatively
regulates Msp58, we next examined whether EDD affects Msp58 pro-
tein turnover. HeLa cells transfected with either EDD or GFP siRNAs
were harvested at different time points (0–24 h) after protein synthesis
was blocked by cycloheximide (CHX) and analyzed by immunoblotting
(Fig. 5B). Quantiﬁcation of immunoblots indicates that knockdown EDD
signiﬁcantly increased Msp58's half-life from ~8 to ~20 h (Fig. 5C).
Taken together, these results strongly support our viewof EDD as a neg-
ative regulator of Msp58.
3.7. Msp58 is degraded by the ubiquitin–proteasome pathway
The ubiquitin–proteasome pathway plays a crucial role in protein
degradation. As our previous data showed that Msp58 turnover is neg-
atively controlled by E3 ubiquitin protein ligase EDD (Fig. 5), we there-
fore further investigated whether Msp58 is regulated by the ubiquitin–
proteasome pathway. To determinewhether the proteasome is involved
in the degradation of Msp58, we treatedWI-38, HeLa andHEK293T cells
with proteasome inhibitor MG132 and examined its effect on the pro-
tein levels of Msp58, by immunoblotting. In these experiments, cells
were also treated with cycloheximide to inhibit nascent protein synthe-
sis. As expected, Msp58 protein levels in cycloheximide treated cells
were signiﬁcantly reduced (Fig. 6A, lanes 2, 5 and 8), but the levels of
Msp58 were partially restored in cells simultaneously treated with
cycloheximide andMG132 (Fig. 6A, lanes 3, 6 and 9). These results dem-
onstrate that Msp58 undergoes proteasome-mediated degradation.
As protein degradation by the proteasome requires the substrates
to be post-translationally modiﬁed by ubiquitination, we next studied
whether Msp58 is ubiquitinated and the role of EDD E3 ubiquitin
ligase in this process. We used the in vivo ubiquitination assay,
where lysates from HEK293T cells co-transfected with HA-ubiquitin
and GFP-Msp58 (or control GFP) expression constructs, with or with-
out EDD siRNAs, were immunoprecipitated with anti-HA afﬁnity
matrix (Fig. 6B). The eluates (lanes 4–6 and 10–12), as well as the
inputs (lanes 1–3 and 7–9), were then examined by immunoblotting
with antibodies against Msp58 (lanes 1–6) and GFP (lanes 7–12).
Our results show that the exogenously expressed GFP-Msp58 was
ubiquitinated, but the level of ubiquitinated GFP-Msp58 was not sig-
niﬁcantly affected by silencing EDD.
3.8. Msp58 and EDD regulate cyclin levels and cell cycle progression
In the knockdown studies, we noticed that depletion of Msp58
resulted in a signiﬁcant increase in the number of viable cells, whereas
silencing EDD displayed an opposite phenotype. We reasoned that this
might be, at least in part, due to the changes of Msp58 protein level,
since Msp58 has been shown to affect cell cycle progression through
its known effects on cyclin gene expression [8,9]. To explore this hy-
pothesis, we used propidium iodide labeling and ﬂow cytometry to ex-
amine cell cycle phases in WI-38 cell cultures treated with siRNAs to
EDD, to Msp58, or to both. Seventy-two hours after transfection with
siRNAs, subconﬂuent cells were harvested and analyzed (Fig. 7,
Table 1). The results showed that, compared with the control (GFP
siRNA-transfected cells), depletion of EDD did not signiﬁcantly affect
G1, but led to a 66% rise in the number of cells in S and a 38% decrease
in the G2/M population. Silencing Msp58 reduced the percentage of
Fig. 3. Two independent regions of Msp58 can bind EDD. (A) Schematic diagram of Msp58 with predicted domains and its derivative fragments used to test their binding with EDD. (B) The
lysates of uninduced (U, lanes 1, 3 and 5) and induced (I, lanes 2,4 and 6) bacteria, co-expressing EDDFR4-S with His6-Msp58 (or His6- Msp581-296 or His6- Msp58297–462), were resolved by
SDS-PAGE, followed by immunoblotting with anti-His6 tag and anti-S tag antibodies. (C) Msp58297–462 contains an EDD interacting domain. S-protein agarose was incubated with the lysate
frombacteria co-expressing EDDFR4-SwithHis6-Msp58 (orMsp58 fragments). The unbound (U, lanes 1, 3 and 5) and bound (B, lanes 2, 4 and 6) proteinswere examined by immunoblotting
with anti-His6 tag antibody. Asterisks point to degradation fragments. (D) The lysates of uninduced (U, lanes 1 and 3) and induced (I, lanes 2 and 4) bacteria, co-expressing EDDFR4-S with
His6-Msp581–342 (lanes 1 and 2) or Msp58343–462 (lanes 3 and 4), were examined as described in (B). (E) Both His6-Msp581–342 (lane 4) and Msp58343–462 (lane 6) are able to bind EDD.
The experiments were performed as described in (C). His6-Msp581-296 (lanes 1 and 2) served as a negative control. Asterisks point to degradation fragments.
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Fig. 4. EDD co-localizes with Msp58 in the nucleoplasm of mammalian cells. (A) Immnunostaining of HeLa cells with mouse monoclonal antibody mAb414 and rabbit polyclonal
anti-Msp58 (top) or anti-EDD (bottom) antibodies. (B) WI-38 (top) and HeLa (bottom) cells were immunostained with rabbit polyclonal anti-Msp58 and mouse polyclonal
anti-EDD antibodies. (C) HeLa cells transfected with GFP-Msp58 expression construct were immunostained with the rabbit polyclonal antibodies against EDD. Bars: 10 μm.
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in the percentage of cells in S (up 55%), but most notably, there was an
increase (not a decrease) in the G2/M population (up 50%) (Table 1,
Fig. 7B). Co-depletion of Msp58 and EDD brought both G1 and G2/M
populations back to control levels, but retained a small increase in the
S population (up 25%) (Table 1). Overall, our data indicated that individ-
ual depletion of Msp58 or EDD affected different phases of the cell cycle,
while simultaneous depletion partially reverted these phenotypes.Msp58 has been implicated in regulating the expression of several
cyclins [8,9,28]. As signiﬁcant changes in cell cycle progression were
observed in Msp58- or EDD-depleted cells, we therefore examined
whether the levels of cyclins were affected. As shown in Fig. 7C,
EDD depleted cells showed an increase of cyclins D1 and E, whereas
knocking down Msp58 resulted in an accumulation of cyclins B and
D3. When both Msp58 and EDD were depleted, the levels of cyclins
B, D1 and E reverted to levels similar to those in control samples.
Fig. 5. EDD negatively regulates the protein level and stability of Msp58. (A) Depletion of EDD resulted in higher Msp58 protein levels in WI-38, HeLa and HEK293T cells.
Seventy-two hours after transfection with either EDD (lanes 2, 4 and 6) or control (lanes 1, 3 and 5) siRNAs, the cells were harvested and analyzed by immunoblotting with the
speciﬁed antibodies. (B) EDD knockdown increased Msp58 protein stability. HeLa cells were transfected with EDD or control siRNAs, and 72 h after transfection cells were treated
with CHX. At the indicated time points, cells were harvested and analyzed by immunoblotting. (C). A semi-log graph showing the half-lives of Msp58 as shown in (B). The trendlines
are derived from the raw data regression.
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cyclin expression and cell cycle progression.
4. Discussion
Msp58's roles in transcriptional regulation and cell proliferation
remain poorly understood. In this work, we have identiﬁed ubiquitin
E3 ligase EDD as a novel interacting partner of Msp58, and shown that
Msp58 and EDD colocalize in the nucleus of mammalian cells. Since
we found that the level of Msp58 was increased in EDD depleted
cells, one possibility is that EDD ubiquitinates Msp58, leading to its
degradation through the ubiquitin–proteasome pathway. Consistent
with this hypothesis, we showed an accumulation of Msp58 in cells
treated with the proteasome inhibitor MG132 (Fig. 6A). Others have
seen similar effects onMsp58 in cells with impaired proteasomal activity
[4]. In addition, we demonstrated the ubiquitination of ectopically
expressed GFP-Msp58 in HEK293T cells, which, interestingly, was not af-
fected by knocking downEDD (Fig. 6B). This shows that ubiquitination of
exogenous Msp58 can occur in an EDD-independent manner. However,
as low protein levels precluded the study of endogenous Msp58 under
our experimental conditions, it remains possible that EDD's effect on
Msp58 protein levels is through direct ubiquitination. Notably, EDD(also called UBR5) is a member of a family of E3 ubiquitin ligases
known as N-recognins, which target substrates that contain N-degrons
for their degradation via the N-end rule pathway. EDD recognizes type
1 N-degron (11). A putative degron sequence at the N-terminus of
Msp58 was disrupted by the insertion of GFP, perhaps explaining the
absence of EDD-mediated ubiquitination of this ectopically expressed
protein. Currently, we are investigating the mechanism by which EDD
controls the protein level of endogenous Msp58.
An alternative but not mutually exclusive possibility is that Msp58
serves as an adaptor protein for recruiting other substrates to EDD. In-
deed, previous work provides an example of this idea: the adaptor
protein VPRBP recruits the substrate katanin p60 to the EDD ubiquitin
ligase complex [26]. During mapping of the EDD-interacting region of
Msp58, we found to our surprise that two domains of Msp58
(Msp581–342 and Msp58343–462) were each sufﬁcient to bind EDD
(Fig. 3). Msp581–342 contains a coiled-coil motif and Msp58343–462
has an FHA (forkhead-associated) domain; both are known to mediate
protein–protein interactions. We speculate that, with two EDD-binding
regions, Msp58 has more ﬂexibility to interact with different proteins
while still maintaining its ability to bind EDD. With this capability,
Msp58 would be able to recruit a broad range of proteins to EDD for
ubiquitination, and thus regulate their stability, localization and/or
Fig. 6. Msp58 is regulated by the ubiquitin–proteasome pathway. (A) Msp58 protein level is controlled by the proteasome. Before harvest, WI-38, HeLa and HEK293T cells were
treated with cycloheximide (CHX; lanes 2, 3, 5, 6, 8 and 9), with (lanes 3, 6 and 9) or without (lanes 2, 5 and 8) MG132, for 6 h. The lysates were analyzed by immunoblotting
with speciﬁed antibodies. (B) GFP-Msp58 was ubiquitinated in vivo and knockdown of EDD had no obvious effect on the level of ubiquitinated GFP-Msp58. HEK293T cells were
co-transfected with HA-ubiquitin and GFP-Msp58 expression constructs, with or without EDD siRNAs. Cells co-transfected with HA-Ubiquitin and GFP were used as control. Lysates
were immunoprecipitated with anti-HA afﬁnity matrix and the inputs (lanes 1–3 and 7–9) and eluates (lanes 4–6 and 10–12) were examined by immunoblotting with speciﬁed
antibodies.
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interacting partner of several proteins involved in diverse nuclear
processes [1–6]. We are currently examining whether some of these
Msp58-associated proteins undergo EDD-mediated ubiquitination.
As previously mentioned, two independent regions of Msp58
(Msp581–342 and Msp58343–462) are able to interact with EDDFR4
fragment (amino acids 1976–2474). EDDFR4, located upstream of the
HECT domain that contains the ubiquitin E3 ligase activity, contains a car-
boxyl region of poly (A)-binding protein (PABP)-like domain (PABP-C,
amino acids 2391–2455) and overlaps with the region (amino acids
889–2526) that interacts with the FHA domain of checkpoint kinase
CHK2. Msp58 also contains an FHA domain (amino acids 362–432) and
our studies demonstrated that Msp58343–462 is sufﬁcient to bind
EDDFR4. Therefore, it is possible that Msp58 competes with CHK2 for
the same binding region of EDD. Future studies will be carried out to
test this hypothesis.
Our results showed that both increases and decreases in Msp58
protein affected the expression of several cyclins and cell cycle pro-
gression. Msp58 depleted cells showed an accumulation of cyclins B
and D3 and a decrease of cyclin E (Fig. 7C). At the same time, these
cells showed a decrease in G1 and an increase in S and G2/M pop-
ulations (Table 1, Fig. 7B). D3 is a G1 cyclin that promotes the transi-
tion from G1 to S, while cyclin B is up in G2 and M phases and must
be degraded for cells to exit M and enter the G1 phase. The
up-regulation of cyclins D3 and B in Msp58 depleted cells, therefore, is
consistent with their cell cycle proﬁle (an increase in both S and G2/M
and a decrease in G1). Recently, Hsu et al. reported that overexpression
of Msp58 in human ﬁbrosarcoma HT1080 cells down-regulates thelevels of cyclins A, B1, D and E2 and Msp58 controls cell proliferation
in a cell-type dependent manner[9].
Depleting EDD led to an increase of Msp58, low cyclin B and a
reduced G2/M compartment (Fig. 7, Table 1). This is the opposite phe-
notype to that of Msp58 depletion, suggesting an inverse relationship
between Msp58 levels and accumulation of cells at the G2/M phase of
the cell cycle. Certainly, we cannot assume that all the cell cycle
effects seen upon EDD depletion are due only to the increase in
Msp58 levels, since EDD previously has been shown to regulate cell
cycle progression [12–14]. Nevertheless, it is clear that a decrease in
Msp58 modiﬁes cell cycle progression, and since EDD determines
whether Msp58 protein levels are high or low, the Msp58/EDD inter-
action must serve an important regulatory role in this process.
The changes in cyclin levels that accompanied Msp58 depletion (and
Msp58 increases caused by EDD depletion) are consistent with earlier
studies that showed that MCRS2, a Drosophila homolog of human
Msp58, stimulates transcription of a subset of cyclin genes by recruiting
the RNA polymerase II complex to their promoters [8]. Msp58 is likely to
affect the cell cycle through other mechanisms as well. For example,
Meunier and Vernos have recently reported that Msp58/MCRS1 is
required for spindle assembly and regulates the stability of kinetochore
spindles [7]. Aberrant expression of Msp58 results in cell cycle arrest in
mitosis [7].
Surprisingly, when EDDwas co-silencedwithMsp58, the depletion of
Msp58 was less pronounced. We interpret this as further evidence of
EDD's negative effect on Msp58; both EDD and Msp58 siRNA contribute
to the depletion of Msp58 protein in Msp58 knockdown samples. In
co-depleted cells, EDD's regulatory function was compromised, allowing
Fig. 7. Msp58 and EDD regulate cell cycle progression. (A) Representative FACS histograms of WI-38 cells transfected with speciﬁed siRNAs. (B) Analysis of the G2/M phase of the
cell cycle. Bars show relative populations of WI-38 cells transfected with speciﬁed siRNAs as compared with the cells transfected with GFP siRNAs. Data presented as means±SD
(n=5). (C) Representative immunoblots showing the levels of cyclins (B, D1, D3, and E) in different siRNA-transfected samples. The protein bands were semi-quantiﬁed using
ImageJ software, and the numbers on top of blots represent the relative levels of cyclins normalized to control siRNA-transfected sample.
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protein to near-control levels in the co-depletion sample, the G2/M pop-
ulation also largely returned to normal. These ﬁndings further conﬁrm
EDD's ability to negatively regulate Msp58 and the importance of this
Msp58/EDD interaction to cell cycle progression.Table 1
Msp58 and EDD regulate cell cycle progression.
siRNAs Phases G1 S G2–M
Control 68.5±3.7 10.7±1.3 20.7±3.3
EDD 69.4±4.0 17.8±3.2* 12.9±2.1*
Msp58 52.1±2.7* 16.6±4.7* 31.3±5.3*
EDD and Msp58 67.0±2.6 13.4±2.7* 19.6±1.2
Note: n=5; means±SD. (*, pb0.05 in comparison with control siRNA).5. Conclusion
In this study, we have identiﬁed a physical and functional inter-
action between EDD and Msp58. EDD directly binds and regulates
Msp58, and both proteins modulate cyclin levels and cell cycle pro-
gression. Since Msp58 and EDD are often aberrantly expressed in
cancers [11,22,28,29], our ﬁndings shed light on the mechanism of
their roles in tumorigenesis.
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